Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2018

01-04-2018 | Original Article

Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis

Authors: Alban Benezech, Nadine Desmazes-Dufeu, Karine Baumstarck, Michel Bouvier, Bérengère Coltey, Martine Reynaud-Gaubert, Véronique Vitton

Published in: Digestive Diseases and Sciences | Issue 4/2018

Login to get access

Abstract

Background

Patients with cystic fibrosis (CF) are deemed at risk of developing urinary incontinence (UI) due to repeated coughing and other factors causing increased pressure on the pelvic floor. Fecal incontinence (FI) is probably derived from the same mechanism, but only very few data are available on its frequency.

Aims

The aim of this study was to determine the prevalence of FI in an adult population with CF.

Methods

This retrospective study was conducted from January 2012 to June 2014. Patients were recruited from Marseille referral center for adult CF. They were asked to fill in a self-completed anonymous questionnaire for symptom assessment of UI and FI. Clinical data and a detailed history of CF were also recorded.

Results

A total of 155 out of 190 patients (92 females) of mean age 30.5 ± 11 years completed the survey. Seventy-three patients (47%) were lung transplanted. Forty patients (25.8%) reported FI with a mean St Mark’s score of 4.9 ± 2. Thirty-five patients (22.6%) reported UI. Eighteen patients (11.6%) reported both FI and UI. FI was significantly more frequent in older patients (34.27 vs. 29.54 years, p = 0.03) and in patients with associated UI (p = 0.001). No relationship was found between respiratory, bacterial, nutritional status, transplantation, pancreatic status, practice of physiotherapy, delivery history, and FI.

Conclusions

The high prevalence of FI in CF and its negative impacts need to integrate this symptom in the overall treatment of this pathology. The systematic early detection of FI may allow its rapid management and limit their consequences.
Literature
1.
go back to reference Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations–correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606.CrossRefPubMed Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations–correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606.CrossRefPubMed
2.
go back to reference Cornacchia M, Zenorini A, Perobelli S, Zanolla L, Mastella G, Braggion C. Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int. 2001;88:44–48.CrossRefPubMed Cornacchia M, Zenorini A, Perobelli S, Zanolla L, Mastella G, Braggion C. Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int. 2001;88:44–48.CrossRefPubMed
3.
go back to reference Dodd ME, Langman H. Urinary incontinence in cystic fibrosis. J R Soc Med 2005:28–36. Dodd ME, Langman H. Urinary incontinence in cystic fibrosis. J R Soc Med 2005:28–36.
4.
go back to reference Moran F, Bradley JM, Boyle L, Elborn JS. Incontinence in adult females with cystic fibrosis: a Northern Ireland survey. Int J Clin Pract. 2003;57:182–183.PubMed Moran F, Bradley JM, Boyle L, Elborn JS. Incontinence in adult females with cystic fibrosis: a Northern Ireland survey. Int J Clin Pract. 2003;57:182–183.PubMed
5.
go back to reference Vella M, Cartwright R, Cardozo L, Parsons M, Madge S, Burns Y. Prevalence of incontinence and incontinence-specific quality of life impairment in women with cystic fibrosis. Neurourol Urodyn. 2009;28:986–989.CrossRefPubMed Vella M, Cartwright R, Cardozo L, Parsons M, Madge S, Burns Y. Prevalence of incontinence and incontinence-specific quality of life impairment in women with cystic fibrosis. Neurourol Urodyn. 2009;28:986–989.CrossRefPubMed
6.
go back to reference Nixon GM, Glazner JA, Martin JM, Sawyer SM. Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics. 2002;110:e22.CrossRefPubMed Nixon GM, Glazner JA, Martin JM, Sawyer SM. Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics. 2002;110:e22.CrossRefPubMed
7.
go back to reference Haab F, Richard F, Amarenco G, et al. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology. 2008;71:646–656.CrossRefPubMed Haab F, Richard F, Amarenco G, et al. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology. 2008;71:646–656.CrossRefPubMed
9.
go back to reference Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464–1486.CrossRefPubMed Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464–1486.CrossRefPubMed
10.
go back to reference Button B, Sherburn M, Chase J, McLachan Z, Kotsimbos T, Wilson J. Urinary incontinence and bowel problems in women with CF and chronic obstructive pulmonary disease (COPD) compared with controls. J Cyst Fibros. 2004;3:S94. Button B, Sherburn M, Chase J, McLachan Z, Kotsimbos T, Wilson J. Urinary incontinence and bowel problems in women with CF and chronic obstructive pulmonary disease (COPD) compared with controls. J Cyst Fibros. 2004;3:S94.
11.
go back to reference White D, Stiller K. The prevalence of incontinence pre- and post-lung transplantation. Internet J Allied Heal Sci Pract 2007;5. White D, Stiller K. The prevalence of incontinence pre- and post-lung transplantation. Internet J Allied Heal Sci Pract 2007;5.
12.
go back to reference White K, Stiller K, Roney F. The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients. Physiother Theory Pr. 2000;16:35–42.CrossRef White K, Stiller K, Roney F. The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients. Physiother Theory Pr. 2000;16:35–42.CrossRef
13.
go back to reference Chambers R, Lucht A, Reihill A, Hough J. Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey. Int Urogynecol J 2016. Chambers R, Lucht A, Reihill A, Hough J. Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey. Int Urogynecol J 2016.
14.
go back to reference Moraes T, Carpenter S, Taylor L. Cystic fibrosis and incontinence in children. Pediatr Pulmonol. 2002;110:a398. Moraes T, Carpenter S, Taylor L. Cystic fibrosis and incontinence in children. Pediatr Pulmonol. 2002;110:a398.
15.
go back to reference Macmillan AK, Merrie AEH, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47:1341–1349.CrossRefPubMed Macmillan AK, Merrie AEH, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47:1341–1349.CrossRefPubMed
16.
go back to reference Faltin DL, Sangalli MR, Curtin F, Morabia A, Weil A. Prevalence of anal incontinence and other anorectal symptoms in women. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:117–120; discussion 121. Faltin DL, Sangalli MR, Curtin F, Morabia A, Weil A. Prevalence of anal incontinence and other anorectal symptoms in women. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:117–120; discussion 121.
17.
go back to reference Damon H, Guye O, Seigneurin A, et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol. 2006;30:37–43.CrossRefPubMed Damon H, Guye O, Seigneurin A, et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol. 2006;30:37–43.CrossRefPubMed
18.
go back to reference Bharucha AE, Zinsmeister AR, Locke GR, Schleck C, McKeon K, Melton LJ. Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol. 2006;4:1004–1009.CrossRefPubMed Bharucha AE, Zinsmeister AR, Locke GR, Schleck C, McKeon K, Melton LJ. Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol. 2006;4:1004–1009.CrossRefPubMed
20.
go back to reference Reichman G, De Boe V, Braeckman J, Michielsen D. Urinary incontinence in patients with cystic fibrosis. Scand J Urol. 2016;50:128–131.CrossRefPubMed Reichman G, De Boe V, Braeckman J, Michielsen D. Urinary incontinence in patients with cystic fibrosis. Scand J Urol. 2016;50:128–131.CrossRefPubMed
21.
go back to reference Ng K-S, Sivakumaran Y, Nassar N, Gladman MA. Fecal incontinence: community prevalence and associated factors—a systematic review. Dis Colon Rectum. 2015;58:1194–1209.CrossRefPubMed Ng K-S, Sivakumaran Y, Nassar N, Gladman MA. Fecal incontinence: community prevalence and associated factors—a systematic review. Dis Colon Rectum. 2015;58:1194–1209.CrossRefPubMed
22.
go back to reference Vitton V, Baumstarck-Barrau K, Brardjanian S, Caballe I, Bouvier M, Grimaud J-C. Impact of high-level sport practice on anal incontinence in a healthy young female population. J Womens Health. 2011;20:757–763.CrossRef Vitton V, Baumstarck-Barrau K, Brardjanian S, Caballe I, Bouvier M, Grimaud J-C. Impact of high-level sport practice on anal incontinence in a healthy young female population. J Womens Health. 2011;20:757–763.CrossRef
24.
go back to reference Bharucha AE, Fletcher JG, Melton LJ, Zinsmeister AR. Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol. 2012;107:902–911.CrossRefPubMedPubMedCentral Bharucha AE, Fletcher JG, Melton LJ, Zinsmeister AR. Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol. 2012;107:902–911.CrossRefPubMedPubMedCentral
25.
go back to reference Bharucha AE, Zinsmeister AR, Schleck CD, Melton LJ. Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology. 2010;139:1559–1566.CrossRefPubMedPubMedCentral Bharucha AE, Zinsmeister AR, Schleck CD, Melton LJ. Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology. 2010;139:1559–1566.CrossRefPubMedPubMedCentral
26.
go back to reference De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. AJP Gastrointest Liver Physiol. 2007;293:G104–G111.CrossRef De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. AJP Gastrointest Liver Physiol. 2007;293:G104–G111.CrossRef
28.
go back to reference Bazett M, Bergeron M-E, Haston CK. Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model. Sci Rep. 2016;6:19189.CrossRefPubMedPubMedCentral Bazett M, Bergeron M-E, Haston CK. Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model. Sci Rep. 2016;6:19189.CrossRefPubMedPubMedCentral
29.
go back to reference Wouthuyzen-Bakker M, Bijvelds MJC, de Jonge HR, De Lisle RC, Burgerhof JGM, Verkade HJ. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res. 2012;71:4–12.CrossRefPubMedPubMedCentral Wouthuyzen-Bakker M, Bijvelds MJC, de Jonge HR, De Lisle RC, Burgerhof JGM, Verkade HJ. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res. 2012;71:4–12.CrossRefPubMedPubMedCentral
30.
go back to reference de Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil. 2010;22:341-e87.CrossRefPubMed de Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil. 2010;22:341-e87.CrossRefPubMed
31.
go back to reference Sapsford RR, Hodges PW. Contraction of the pelvic floor muscles during abdominal maneuvers. Arch Phys Med Rehabil. 2001;82:1081–1088.CrossRefPubMed Sapsford RR, Hodges PW. Contraction of the pelvic floor muscles during abdominal maneuvers. Arch Phys Med Rehabil. 2001;82:1081–1088.CrossRefPubMed
32.
go back to reference Deffieux X, Raibaut P, Rene-Corail P, et al. External anal sphincter contraction during cough: not a simple spinal reflex. Neurourol Urodyn. 2006;25:782–787.CrossRefPubMed Deffieux X, Raibaut P, Rene-Corail P, et al. External anal sphincter contraction during cough: not a simple spinal reflex. Neurourol Urodyn. 2006;25:782–787.CrossRefPubMed
33.
go back to reference Amarenco G, Ismael SS, Lagauche D, et al. Cough anal reflex: strict relationship between intravesical pressure and pelvic floor muscle electromyographic activity during cough. Urodynamic and electrophysiological study. J Urol. 2005;173:149–152.CrossRefPubMed Amarenco G, Ismael SS, Lagauche D, et al. Cough anal reflex: strict relationship between intravesical pressure and pelvic floor muscle electromyographic activity during cough. Urodynamic and electrophysiological study. J Urol. 2005;173:149–152.CrossRefPubMed
34.
go back to reference Deffieux X, Hubeaux K, Porcher R, Ismael SS, Raibaut P, Amarenco G. Abnormal pelvic response to cough in women with stress urinary incontinence. Neurourol Urodyn. 2008;27:291–296.CrossRefPubMed Deffieux X, Hubeaux K, Porcher R, Ismael SS, Raibaut P, Amarenco G. Abnormal pelvic response to cough in women with stress urinary incontinence. Neurourol Urodyn. 2008;27:291–296.CrossRefPubMed
35.
go back to reference Selvadurai HC, Allen J, Sachinwalla T, Macauley J, Blimkie CJ, Van Asperen PP. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003;168:1476–80. Selvadurai HC, Allen J, Sachinwalla T, Macauley J, Blimkie CJ, Van Asperen PP. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003;168:1476–80.
36.
go back to reference Szeinberg A, England S, Mindorff C, Fraser IM, Levison H. Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished, young adult male patients with cystic fibrosis. Am Rev Respir Dis. 1985;132:766–769.PubMed Szeinberg A, England S, Mindorff C, Fraser IM, Levison H. Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished, young adult male patients with cystic fibrosis. Am Rev Respir Dis. 1985;132:766–769.PubMed
37.
go back to reference Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58:752–756.CrossRefPubMedPubMedCentral Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58:752–756.CrossRefPubMedPubMedCentral
38.
go back to reference Mirakhur A, Walshaw MJ. Autonomic dysfunction in cystic fibrosis. J R Soc Med 2003:11–7. Mirakhur A, Walshaw MJ. Autonomic dysfunction in cystic fibrosis. J R Soc Med 2003:11–7.
39.
go back to reference Cobb WS, Burns JM, Kercher KW, Matthews BD, James Norton H, Todd HenifordB. Normal intraabdominal pressure in healthy adults. J Surg Res. 2005;129:231–235.CrossRefPubMed Cobb WS, Burns JM, Kercher KW, Matthews BD, James Norton H, Todd HenifordB. Normal intraabdominal pressure in healthy adults. J Surg Res. 2005;129:231–235.CrossRefPubMed
40.
go back to reference Kerem E, Wilschanski M, Miller NL, et al. Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis. J Cyst Fibros. 2011;10:193–200.CrossRefPubMed Kerem E, Wilschanski M, Miller NL, et al. Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis. J Cyst Fibros. 2011;10:193–200.CrossRefPubMed
Metadata
Title
Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis
Authors
Alban Benezech
Nadine Desmazes-Dufeu
Karine Baumstarck
Michel Bouvier
Bérengère Coltey
Martine Reynaud-Gaubert
Véronique Vitton
Publication date
01-04-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4825-2

Other articles of this Issue 4/2018

Digestive Diseases and Sciences 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.